<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The ability to eliminate malignant cells from bone marrow (BM) while retaining sufficient numbers of <z:mpath ids='MPATH_458'>normal</z:mpath> progenitors to ensure engraftment, may well establish the future of autologous BM transplantation (ABMT) for <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematologic malignancies</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>In this study, we describe the effects of <z:chebi fb="0" ids="6888">methylprednisolone</z:chebi> (MP) and <z:chebi fb="0" ids="4911">etoposide</z:chebi> (<z:chebi fb="0" ids="4911">VP16</z:chebi>) alone or in combination on 5 tumor cell lines (<z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e>-60, a promyelocytic cell line; Molt-4, a T cell <z:hpo ids='HP_0001909'>leukemia</z:hpo>; Daudi, a Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and R10/8226 and R40/8226, <z:chebi fb="0" ids="28748">doxorubicin</z:chebi>-resistant <z:mp ids='MP_0009440'>myeloma</z:mp> cell lines) </plain></SENT>
<SENT sid="2" pm="."><plain>The <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cell kill efficiency of the drugs was assayed using the limiting dilution assay </plain></SENT>
<SENT sid="3" pm="."><plain>We determined the toxic effect on progenitor cells by assaying granulocyte-macrophage colony-forming units (CFU) </plain></SENT>
<SENT sid="4" pm="."><plain>With a combination of MP at 10(-3) M and <z:chebi fb="0" ids="4911">VP16</z:chebi> at 75 microM, we observed the following log reduction in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cell clones: <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e>-60, 4.695 +/- 0.001; Molt-4, 3.626 +/- 0.036; Daudi, 5.633 +/- 0.001; R10/8226, 3.052 +/- 0.544; R40/8226, 3.126 +/- 0.080 </plain></SENT>
<SENT sid="5" pm="."><plain>CFU recovery was 24% +/- 5% </plain></SENT>
<SENT sid="6" pm="."><plain>Mixing <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cell lines with a 20-fold excess of <z:mpath ids='MPATH_458'>normal</z:mpath> irradiated BM cells did not eliminate the inhibitory effect of the drug combination </plain></SENT>
<SENT sid="7" pm="."><plain>We propose that MP and <z:chebi fb="0" ids="4911">VP16</z:chebi> used in concert produce effective purging of malignant hematopoietic cells from BM while sparing <z:mpath ids='MPATH_458'>normal</z:mpath> progenitors needed for engraftment </plain></SENT>
</text></document>